As cited
Copy frozen at (site build).
industry
Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform
Biomemory introduced DNA Shield, a commercial product derived from its molecular information technology platform. The company acquired catalog's assets and appointed Laurent Guengant as chief executive earlier in 2026.
Why it matters: Organizations evaluating emerging storage and security technologies should monitor DNA-based solutions as a potential alternative to traditional data protection methods.
- Source published
- First seen by Cybersecurity Tracker